Literature DB >> 33059160

CytoGPS: A large-scale karyotype analysis of CML data.

Zachary B Abrams1, Suli Li2, Lin Zhang3, Caitlin E Coombes2, Philip R O Payne3, Nyla A Heerema4, Lynne V Abruzzo4, Kevin R Coombes5.   

Abstract

Karyotyping, the practice of visually examining and recording chromosomal abnormalities, is commonly used to diagnose diseases of genetic origin, including cancers. Karyotypes are recorded as text written in the International System for Human Cytogenetic Nomenclature (ISCN). Downstream analysis of karyotypes is conducted manually, due to the visual nature of analysis and the linguistic structure of the ISCN. The ISCN has not been computer-readable and, as such, prevents the full potential of these genomic data from being realized. In response, we developed CytoGPS, a platform to analyze large volumes of cytogenetic data using a Loss-Gain-Fusion model that converts the human-readable ISCN karyotypes into a machine-readable binary format. As proof of principle, we applied CytoGPS to cytogenetic data from the Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer, a National Cancer Institute hosted database of over 69,000 karyotypes of human cancers. Using the Jaccard coefficient to determine similarity between karyotypes structured as binary vectors, we were able to identify novel patterns from 4,968 Mitelman CML karyotypes, such as the co-occurrence of trisomy 19 and 21. The CytoGPS platform unlocks the potential for large-scale, comparative analysis of cytogenetic data. This methodological platform is freely available at CytoGPS.org.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Bioinformatics; Chronic myeloid leukemia; CytoGPS; Cytogenetics; Data science; Karyotypes

Mesh:

Year:  2020        PMID: 33059160      PMCID: PMC8126981          DOI: 10.1016/j.cancergen.2020.09.005

Source DB:  PubMed          Journal:  Cancer Genet


  14 in total

Review 1.  Structure, mechanism, and evolution of the mRNA capping apparatus.

Authors:  S Shuman
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2001

Review 2.  Fluorescence in situ Hybridization (FISH).

Authors:  Jane Bayani; Jeremy A Squire
Journal:  Curr Protoc Cell Biol       Date:  2004-09

Review 3.  Historical and Clinical Perspectives on Chromosomal Translocations.

Authors:  Ellen S Wilch; Cynthia C Morton
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

Review 4.  Cytogenetic Nomenclature and Reporting.

Authors:  Marian Stevens-Kroef; Annet Simons; Katrina Rack; Rosalind J Hastings
Journal:  Methods Mol Biol       Date:  2017

5.  Additional trisomies amongst patients with chronic lymphocytic leukemia carrying trisomy 12: the accompanying chromosome makes a difference.

Authors:  Panagiotis Baliakas; Anna Puiggros; Aliki Xochelli; Lesley-Ann Sutton; Florence Nguyen-Khac; Anne Gardiner; Karla Plevova; Eva Minga; Anastasia Hadzidimitriou; Renata Walewska; Helen McCarthy; Margarita Ortega; Rosa Collado; Teresa González; Isabel Granada; Elisa Luño; Jana Kotašková; Theodoros Moysiadis; Zadie Davis; Niki Stavroyianni; Achilles Anagnostopoulos; Jonathan C Strefford; Sarka Pospisilova; Frederic Davi; Anastasia Athanasiadou; Richard Rosenquist; David Oscier; Blanca Espinet; Kostas Stamatopoulos
Journal:  Haematologica       Date:  2016-04-21       Impact factor: 9.941

Review 6.  Cytogenetic and molecular genetic evolution of chronic myeloid leukemia.

Authors:  Bertil Johansson; Thoas Fioretos; Felix Mitelman
Journal:  Acta Haematol       Date:  2002       Impact factor: 2.195

7.  Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining.

Authors:  J D Rowley
Journal:  Nature       Date:  1973-06-01       Impact factor: 49.962

8.  SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations.

Authors:  M Meggendorfer; U Bacher; T Alpermann; C Haferlach; W Kern; C Gambacorti-Passerini; T Haferlach; S Schnittger
Journal:  Leukemia       Date:  2013-04-30       Impact factor: 11.528

9.  Frequent somatic mutations in epigenetic regulators in newly diagnosed chronic myeloid leukemia.

Authors:  E Togasaki; J Takeda; K Yoshida; Y Shiozawa; M Takeuchi; M Oshima; A Saraya; A Iwama; K Yokote; E Sakaida; C Hirase; A Takeshita; K Imai; H Okumura; Y Morishita; N Usui; N Takahashi; S Fujisawa; Y Shiraishi; K Chiba; H Tanaka; H Kiyoi; K Ohnishi; S Ohtake; N Asou; Y Kobayashi; Y Miyazaki; S Miyano; S Ogawa; I Matsumura; C Nakaseko; T Naoe
Journal:  Blood Cancer J       Date:  2017-04-28       Impact factor: 11.037

10.  CytoGPS: a web-enabled karyotype analysis tool for cytogenetics.

Authors:  Zachary B Abrams; Lin Zhang; Lynne V Abruzzo; Nyla A Heerema; Suli Li; Tom Dillon; Ricky Rodriguez; Kevin R Coombes; Philip R O Payne
Journal:  Bioinformatics       Date:  2019-12-15       Impact factor: 6.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.